Patient Centricity and PHASTAR

The clinical research industry is currently undergoing a major shift in their approach towards involving patients in clinical trials as studies are becoming more complex, prices soar and the need for personalised medicine increases. The industry has attempted to do this by developing innovative technology, educating patients and promoting more open lines of communication between industry, physicians, and the media. This has resulted in increased participation and quicker access to market from drug development companies. This article aims to briefly explore the current trends surrounding “patient centricity” and how they can affect the success of a clinical trial.

Over the last 20 years there has been a notable evolution from treating patients as subjects whose sole responsibility is to create data, to treating people, and putting those individuals at the heart of each trial. As physicians and clinical managers have come to realise that the patient experience can ultimately affect the outcome study this understanding has led to the emergence of concept of “patient centricity”.

PHASTAR has highlighted some key areas which have been integral to developing more “patient centric” trials:

  • Technology- Developments in digital technology e.g. eClinical and electronic health systems.
  • Education- Patient input and accommodating protocols for trial participants
  • Patient involvement- Gathering feedback from patient in trial design.
  • Communication- Understanding the importance of speaking directly to your patients, coordinating with physicians and strong transparent relationships with sponsors

PHASTAR understands the importance of including patients in any trial, and to demonstrate this we can offer statistical input into your study design and protocol before sponsors go to clinic which optimises puts the patient’s wellbeing at the centre of the trial and allows our consultants to derive the CORRECT outcomes and conclusions without mistakes and to budget.

PHASTAR also currently uses Medrio, an integrated eClinical software platform with a fully hosted EDC system. This cloud-hosted technology features an easy drag-and-drop interface, allowing study managers to build their studies in days instead of months without requiring any programming. This allows for the data to be collected digitally which minimises human error when collecting data and improves the experience of the patient.